239 related articles for article (PubMed ID: 10949454)
1. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant.
Sánchez Yus E; Simón P; Requena L; Ambrojo P; de Eusebio E
Am J Dermatopathol; 2000 Aug; 22(4):305-10. PubMed ID: 10949454
[TBL] [Abstract][Full Text] [Related]
2. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
3. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification.
Misago N; Inoue T; Koba S; Narisawa Y
J Dermatol; 2013 Jun; 40(6):443-52. PubMed ID: 23414327
[TBL] [Abstract][Full Text] [Related]
4. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
Takai T; Misago N; Murata Y
J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
[TBL] [Abstract][Full Text] [Related]
5. Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
J Dermatol; 2014 May; 41(5):430-4. PubMed ID: 24628407
[TBL] [Abstract][Full Text] [Related]
6. What Is a Solitary Keratoacanthoma? A Benign Follicular Neoplasm, Frequently Associated with Squamous Cell Carcinoma.
Ogita A; Ansai SI
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679546
[TBL] [Abstract][Full Text] [Related]
7. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
8. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
[TBL] [Abstract][Full Text] [Related]
9. Keratoacanthoma: Update on the Debate.
Nirenberg A; Steinman H; Dixon A
Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
[TBL] [Abstract][Full Text] [Related]
10. Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma.
Carr RA; Mesiano D; Heffron C; Radonic T; Wiggins J; Tso S; Agrawal R; Cheung E; Slater DN; Nichols L; Craig P
Pathology; 2023 Oct; 55(6):772-784. PubMed ID: 37573161
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
[TBL] [Abstract][Full Text] [Related]
13. Crater/ulcerated form of infundibular squamous cell carcinoma: A possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma.
Misago N; Inoue T; Nagase K; Tsuruta N; Tara-Hashimoto A; Kimura H; Takahara K; Narita T; Narisawa Y
J Dermatol; 2015 Jul; 42(7):667-73. PubMed ID: 25854192
[TBL] [Abstract][Full Text] [Related]
14. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma.
Randall MB; Geisinger KR; Kute TE; Buss DH; Prichard RW
Am J Clin Pathol; 1990 Feb; 93(2):259-62. PubMed ID: 2301286
[TBL] [Abstract][Full Text] [Related]
15. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
[TBL] [Abstract][Full Text] [Related]
16. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
17. [Keratoacanthomas on recent tattoos: Two cases].
Kluger N; Douvin D; Dupuis-Fourdan F; Doumecq-Lacoste JM; Descamps V
Ann Dermatol Venereol; 2017 Dec; 144(12):776-783. PubMed ID: 29126557
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological study of crateriform verruca: Crateriform epithelial lesions histopathologically distinct from keratoacanthoma.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Oct; 43(10):1154-1159. PubMed ID: 26970425
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of S100 protein-positive cells in inflamed and non-inflamed keratoacanthoma and squamous cell carcinoma.
Korenberg R; Penneys NS; Kowalczyk A; Nadji M
J Cutan Pathol; 1988 Apr; 15(2):104-8. PubMed ID: 3372786
[TBL] [Abstract][Full Text] [Related]
20. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
